News
InteRNA Technologies Establishes Clinical Advisory Board and Appoints New Members to Scientific Advisory Board
October 19, 2021
-- Adding deep preclinical and clinical immuno-oncology expertise to expand InteRNA's preclinical pipeline and accelerate clini...
Read more
InteRNA Appoints Established Oncology Innovator Andrea van Elsas, PhD, to its Supervisory Board
October 12, 2021
Appointment of Andrea van Elsas as a new member of the Company's Supervisory Board.
Read more
Sapreme Boosts Development of its Endosomal Escape Technology Platform and Proprietary Pipeline with EUR 15M Series A
October 07, 2021
Sapreme Boosts Development of its Endosomal Escape Technology Platform and Proprietary Pipeline with EUR 15M Series A
Read more
Merus Presents Early Clinical Data on MCLA-158 and Preclinical Data on Zenocutuzumab at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
October 07, 2021
- Tumor shrinkage and partial responses observed in patients with advanced head and neck squamous cell carcinoma (HNSCC) treate...
Read more
Sapreme Presents Promising New Preclinical Data at 17th Annual Meeting of Oligonucleotide Therapeutics Society
September 27, 2021
Sapreme Presents Promising New Preclinical Data at 17th Annual Meeting of Oligonucleotide Therapeutics Society
Read more
ISA Pharmaceuticals Receives Fast Track Designation for Lead Product ISA101b
September 14, 2021
Fast Track designation for the treatment of recurrent and metastatic HPV16-positive oropharyngeal cancer to improve survival an...
Read more
ORCA Therapeutics B.V. to Start Repeat-Dosing in Phase 1/2a Study of ORCA-010 in TreatmentNaïve Prostate Cancer Patients.
September 07, 2021
ORCA Therapeutics B.V. is pleased to announce the successful completion of the single-dose escalation cohorts of the Phase I/II...
Read more
Stepping to the Exit - Publication in Nature Biotechnology
August 27, 2021
Building a business. Stepping to the exit.
Read more
A Microfluidic 3D Endothelium-on-a-Chip Model to Study Transendothelial Migration of T Cells in Health and Disease
August 02, 2021
Scientists from MIMETAS and Merck introduce an assay to study 3D T cell dynamics under flow and in real-time using a high-throu...
Read more
ISA, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline
July 20, 2021
Grant accelerates clinical development of immunotherapy to treat chronic hepatitis B virus infection
Read more
